ANKRD55 Activators
ANKRD55 Activators are a class of chemical compounds that have the capacity to indirectly enhance the functional activity of ANKRD55 through various signaling pathways and cellular processes. Phorbol 12-myristate 13-acetate (PMA) and Ionomycin are known to activate protein kinase C (PKC) and increase intracellular calcium levels, respectively; both of these actions can lead to the phosphorylation or promotion of protein-protein interactions that involve ANKRD55, particularly in T-cell activation and signaling. Compounds like BAY 11-7082, which inhibits NF-κB, and U0126, a MEK1/2 inhibitor, can also indirectly enhance ANKRD55 activity by initiating compensatory mechanisms within the immune cell signaling network that rely on ANKRD55's role.
Cyclosporine A and FK506, both of which modulate thecalcineurin pathway, can indirectly enhance ANKRD55 activity by affecting the localization of NFAT and modulating T-cell activation, a process in which ANKRD55 is implicated. Similarly, Thapsigargin, by elevating cytosolic calcium levels, can stimulate calcium-dependent enzymes that work with ANKRD55 in signaling pathways. Inhibition of signaling molecules, such as with Gö 6983 for PKC, SB 203580 for p38 MAPK, Rapamycin for mTOR, LY294002 for PI3K, and PD98059 for MEK, can elicit a cellular response that enhances the functions of ANKRD55.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC), which phosphorylates a multitude of substrates within the cell. PKC activation enhances ANKRD55 activity by phosphorylation or by influencing the scaffolding functions of ANKRD55 in immunological synapse formation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium, leading to the activation of calcium-dependent signaling pathways. This elevation in calcium can enhance ANKRD55 activity indirectly by promoting the activation of calcium-dependent enzymes that interact with ANKRD55 in immunological signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation by blocking IκBα phosphorylation. This inhibition can lead to compensatory mechanisms that enhance the function of ANKRD55 in alternative NF-κB signaling pathways. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A inhibits calcineurin, preventing the dephosphorylation and nuclear translocation of NFAT. This inhibition can enhance ANKRD55 activity by stabilizing NFAT in the cytoplasm and promoting ANKRD55's role in T-cell activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to a rise in cytosolic calcium levels. This rise can enhance ANKRD55 activity by stimulating calcium-dependent signaling pathways that involve ANKRD55. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a broad-spectrum PKC inhibitor that disrupts PKC-mediated signaling. The inhibition of certain PKC isoforms can lead to a compensatory enhancement of ANKRD55 activity in T-cell receptor signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that modulates the p38 MAPK signaling pathway. This modulation can enhance ANKRD55 activity by affecting the regulatory mechanisms in which ANKRD55 is implicated within the p38 MAPK pathway. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 binds to FKBP12, creating a complex that inhibits calcineurin. This inhibition can enhance ANKRD55 activity by affecting T-cell activation pathways in which ANKRD55 functions to modulate the localization and activity of NFAT and other transcription factors. | ||||||